Hjem › Gliom › Alabama › Birmingham
Kliniske studier for Gliom i Birmingham, AL
6 studier for Gliom søker deltakere på steder i og rundt Birmingham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RekruttererFase 1/2
- Children's Hospital of Alabama, Birmingham
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RekruttererFase 1
- University of Alabama at Birmingham Cancer Center, Birmingham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RekruttererFase 3
- University of Alabama, Birmingham
Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
RekruttererTidlig fase 1
- UAB, Birmingham
- UAB, Birmingham
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
RekruttererFase 1
- University of Alabama at Birmingham, Children's of Alabama, Birmingham
Gliom-studier i andre byer
- New York City, NY25 studier
- Houston, TX23 studier
- Boston, MA20 studier
- Washington, DC19 studier
- Philadelphia, PA16 studier
- Columbus, OH15 studier
- Miami, FL15 studier
- San Francisco, CA14 studier
- Chicago, IL13 studier
- Durham, NC12 studier
- Seattle, WA11 studier
- St. Louis, MO10 studier
Andre studier i Birmingham
- Kreft (alle typer)31 studier
- Brystkreft24 studier
- Eggstokkreft23 studier
- Fedme23 studier
- Ikke-småcellet lungekreft22 studier
- Akut myelogen leukemi21 studier
- Multipelt myelom18 studier
- KOLS17 studier
- Kardiovaskulær sykdom17 studier
- Type 2-diabetes16 studier
- Endometriekreft16 studier
- Overvekt16 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.